#Trade Shows & Events
Shijiazhuang Pharmaceutical Industry Association Visits Dukon Industrial Park to Chart New Pathways for High-Quality Healthcare Growth
Shijiazhuang healthcare executives and technical experts gather at Dukon Industrial Park to accelerate neurorehabilitation R&D, VTE prevention, and regional supply chain collaboration.
Local industry leaders gather at Dukon's state-of-the-art facility to explore non-invasive brain stimulation, VTE prevention, and collaborative supply chain innovation.
SHIJIAZHUANG, CHINA — July 31, 2026 — On July 30, 2026, the Shijiazhuang Pharmaceutical Industry Association successfully held its "Dukon Industrial Park Study & Exchange Event" at the Dukon Health Technology Industrial Park. Moderated by Huo Sufang, Secretary-General of the Association, the event brought together executives, technical experts, and business leaders from prominent pharmaceutical and medical device enterprises across the region.
The exchange focused on driving industrial synergy, accelerating clinical technology translation, and exploring sustainable, high-quality development strategies for the medical and healthcare sectors.
Fostering Synergy Across the Regional Healthcare Ecosystem
As the host enterprise, Shijiazhuang Dukon Medical Instruments Co., Ltd. welcomed delegates for facility tours, technical presentations, and interactive discussions. The event provided a platform for regional peers to gain firsthand insights into Dukon's advanced manufacturing capabilities, R&D breakthroughs, and strategic vision for neurorehabilitation.
Delegates explored Dukon’s comprehensive portfolio, which spans six core clinical units:
· Neurological Rehabilitation
· Mental Health Rehabilitation
· Pediatric Rehabilitation
· Traditional Chinese Medicine (TCM) Rehabilitation
· Home-Care Rehabilitation
· Critical Care (ICU) Rehabilitation
Showcasing Advanced Non-Invasive Brain Neuromodulation
During the technical showcase, Dukon Medical presented its flagship non-invasive brain stimulation and neuromodulation platforms. Designed to serve hospitals, community health centers, and home care environments, Dukon’s core product lines include:
· Repetitive Transcranial Magnetic Stimulation (rTMS) Systems
· Transcranial Direct Current Stimulation (tDCS) Devices
· Transcranial Ultrasonic Electrotherapy Devices
· Brain Reflex & EEG Therapy Systems
These technologies represent Dukon’s commitment to translating cutting-edge brain science into accessible, painless, and non-traumatic clinical therapies.
Long-Term Vision and Industrial Park Development
In his opening address, Li Bin, General Manager of Dukon Medical, reflected on the company's entrepreneurial journey and outlined its long-term strategic directions.
"The medical and healthcare industry directly impacts human life and health. As a manufacturer, our growth must go beyond market success to embrace broader industry responsibility," stated Mr. Li. "Dukon will continue increasing R&D investment to drive device innovation, ensuring more patients benefit from precise, efficient, and accessible rehabilitation services."
Mr. Li highlighted that the Dukon Health Technology Industrial Park represents more than a manufacturing site—it serves as an open innovation platform integrating intelligent manufacturing, academic exchange, and industrial translation.
Spotlight on VTE Prevention & Clinical Translation
A key highlight of the event was a detailed presentation on Dukon’s Venous Thromboembolism (VTE) Prevention & Treatment Special Project. Technical specialists outlined the clinical application scenarios, device advantages, and hospital implementation pathways for VTE prophylaxis.
By expanding from brain stimulation into comprehensive physical therapy and vascular health management, Dukon demonstrated its growing capacity to address diverse inpatient and post-surgical care needs.
Driving Compliance, Innovation, and Shared Success
In closing remarks, representatives from the Shijiazhuang Pharmaceutical Industry Association commended the event's practical outcomes. The Association encouraged local enterprises to leverage joint exchange platforms, strengthen regulatory compliance, and combine regional industry strengths to enhance Shijiazhuang's standing as a major healthcare innovation hub.
Moving forward under its corporate vision—"Focusing on Brain Rehabilitation, Empowering Healthy Lives"—Dukon Medical will continue working alongside industry partners to build a collaborative, open, and resilient medical technology ecosystem.
Key Takeaways
· Event: Shijiazhuang Pharmaceutical Industry Association Study & Exchange Visit
· Date & Location: July 30, 2026 | Dukon Health Technology Industrial Park, Shijiazhuang, China
· Key Highlights: Delegation tour of Dukon's manufacturing base; presentation of non-invasive brain stimulation technologies (rTMS, tDCS, Ultrasonic Electrotherapy); feature presentation on Dukon's VTE Prevention & Treatment Project.
